Eva Morava-Kozicz
Eva Morava-Kozicz
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of GlcNAc on Tear Production in NGLY1-CDDG | congenital disorder of deglycosylation 1 | Active, not recruiting | Phase 2 | 2026-09-29 | NCT05402345 | |
| AVTX-801 D-galactose Supplementation in SLC35A2-CDG | SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation | Not yet recruiting | Phase 2 | 2026-06-29 | NCT05402384 | |
| Assessing the Safety and Tolerability of NMN in DHDDS-CDG | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DHDDS-CDG, Nutritional and Metabolic Diseases, congenital disorder of glycosylation, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, metabolic disease | Recruiting | Phase 1 | 2026-06-22 | NCT07572825 | |
| Evaluating the Efficacy and Safety of D-galactose in PGM1-CDG (AVTX-801) | PGM1-congenital disorder of glycosylation | Not yet recruiting | Phase 2 | 2026-03-16 | NCT05402332 |